Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
AstraZeneca, Algen Biotechnologies pen $555M AI pact
AstraZeneca has signed a $555 million deal with San Francisco biotech Algen Biotechnologies for new targets in immunology.
Ben Adams
Oct 6, 2025 8:00am
3 scientists win Nobel Prize for discovery of regulatory T cells
Oct 6, 2025 7:03am
Sponsored
Peptide Synthesis and the Hidden Complexities of Scaling Peptide Therapeutics
Oct 6, 2025 8:00am
Leader of NIAID fired in alleged whistleblower retaliation
Oct 3, 2025 12:12pm
Takeda lays off 137 US staff as part of cell therapy retreat
Oct 1, 2025 3:13pm
NIH research grinds to a halt as government shuts down
Oct 1, 2025 12:12pm